MassHunter Quantitative Analysis Software, Version B.07.01, used with Triple Quadrupole Mass Spec...

FDA Device Recall #Z-2359-2019 — Class II — August 15, 2018

Recall Summary

Recall Number Z-2359-2019
Classification Class II — Moderate risk
Date Initiated August 15, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Agilent Technologies, Inc.
Location Santa Clara, CA
Product Type Devices
Quantity 235

Product Description

MassHunter Quantitative Analysis Software, Version B.07.01, used with Triple Quadrupole Mass Spectrometers, models K6460 and K6420 Product Usage: A mass spectrometer for clinical use is a device intended to identify inorganic or organic compounds (e.g., lead, mercury, and drugs) in human specimens by ionizing the compound under investigation and separating the resulting ions by means of an electrical and magnetic field according to their mass.

Reason for Recall

When utilizing specific software versions of an LC/MS device, and Batch at a Glance in Compound Table view, a defect occurs when a new sample(s) is inserted. This defect creates a mismatch between the sample name and the column header whereby the sample header will be offset by one sample. The recalling firm requests that you discontinue using this workflow to generate reports because the Quant batch table will not display fully analyzed results or save any changes made.

Distribution Pattern

US Nationwide. distribution.

Lot / Code Information

Software versions B.07 or below

Other Recalls from Agilent Technologies, Inc.

Recall # Classification Product Date
Z-1544-2025 Class II GenetiSure Dx Labeling Kit, REF: K1201-64105, c... Mar 20, 2025
Z-1384-2022 Class III Kit Label: Anti-FITC-AP CISH Accessory Kit (Da... May 20, 2022
Z-1737-2017 Class II Bond Elut OMS (Dried Matrix Spotting)' Product;... Jun 17, 2015

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.